New York, September 13, 2013 -- Moody's Investor's Service today stated that Walgreen Company's acquisition of Kerr Drug's assets is a modest credit positive but has no impact on its Baa1 senior unsecured rating nor negative outlook.

Vollständigen Artikel bei Moodys lesen